| Novo Nordisk Pharma AG - Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung |
| 65041 | | 01 | | Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml | | Injektionslösung | | A10AE56 | | Insulin Degludec and Liraglutide | | 12.09.2014 | | |
|
| Composition |
| insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insulinum Degludecum | 600 | | Liraglutidum | 3.6 mg/ml | | Nmol | |
| | BAG: Principe actif | Concentr. |
|---|
| Insulinum Degludecum | 100 U | | Liraglutidum | 3.6 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Glycerol | | Sodium Hydroxide | | Phenol | | Zincum |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 3 x 3 ml | 116.91 | 143.55 | B | LS | Oui |
|
